妊娠中晚期细菌性阴道病与妊娠结局的关系

目的检测妊娠中晚期细菌性阴道病（BV）的发病情况并观察分析妊娠中晚期细菌性阴道病与妊娠结局的关系。方法对2009年6月至2012年3月我院收治的360例28～38周孕妇进行BV检测，检出BV阳性62例，将其中40例BV阳性孕妇列为治疗组采用乳酸菌阴道胶囊治疗，剩下22例BV阳性孕妇不做干预列为观察组，而BY阴性的298例孕妇列为对照组，比较三组孕妇的妊娠结局。结果妊娠中晚期细菌性阴道病的发生率为17．2％，治疗组治疗有效率高达92．5％，且观察组患者的早产、胎膜早破、产褥感染及新生儿感染率较其他两组明显增高（P〈0．05）。结论妊娠中晚期细菌性阴道病会提高患者的早产、产褥感染等不良妊娠结局的发生几率，而乳酸菌阴道胶囊治疗可以有效改善BV阳性孕妇的不良妊娠结局。

Relationship between middle and advanced stage bacterial vaginosis and pregnancy outcomes

Objective To investigate the relationship between the incidence of the middle and advanced stage bacterial vaginosis （BV） and pregnancy outcomes, and to observe the incidence of third trimester BY. Methods From June 2009 to March 2012, 360 pregnancy cases in our hospital were detected with BV, 62 cases positive, 40 cases of BV-positive pregnant women as a treatment group using lactobacillus vaginal capsules treatment, the remaining 22 cases of BV-positive pregnant women did not do intervention as observation group, 298 BV-negative pregnant women as a control group, the three groups were compared pregnancy outcomes of pregnant women. Results The late occurrenee of BV in pregnancy was 17.2%, and the observation group pa- tients with preterm labor, premature rupture of membranes, puerperal infection and neonatal infection rate was significantly higher compared to the other two groups （P〈0.05）. Conclusion BV pregnant women increased the probability of occurrence of adverse pregnancy outcomes in patients with preterm labor, puerperal infection, and lactobacillus vaginal capsules treatment can improve the BV positive pregnant women and adverse pregnancy outcomes.